We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$169B
AUM Growth
+$5.04B
Cap. Flow
+$3.65B
Cap. Flow %
2.15%
Top 10 Hldgs %
14.9%
Holding
3,259
New
48
Increased
2,253
Reduced
524
Closed
81

Sector Composition

Rank Sector Weight
1 Technology 17.19%
2 Financials 14.38%
3 Healthcare 12.23%
4 Industrials 10.47%
5 Consumer Discretionary 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACTG icon
2651
Acacia Research
ACTG
$428M
$752K ﹤0.01%
280,548
-8,197
-3% -$22.9K
CNBKA
2652
DELISTED
Century Bancorp Inc/Mass
CNBKA
$750K ﹤0.01%
8,558
-1,975
-19% -$167K
CDMO
2653
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$746K ﹤0.01%
140,734
BFST icon
2654
Business First Bancshares
BFST
$1.04B
$744K ﹤0.01%
30,487
RBB icon
2655
RBB Bancorp
RBB
$448M
$743K ﹤0.01%
37,723
FRST icon
2656
Primis Financial Corp
FRST
$399M
$737K ﹤0.01%
47,869
ACOR
2657
DELISTED
Acorda Therapeutics
ACOR
$737K ﹤0.01%
2,139
+95
+5% +$51.6K
TBIO
2658
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$737K ﹤0.01%
74,330
AKRO
2659
DELISTED
Akero Therapeutics
AKRO
$735K ﹤0.01%
+32,289
New +$751K
IPI icon
2660
Intrepid Potash
IPI
$456M
$735K ﹤0.01%
22,457
+121
+0.5% +$4.04K
IIIV icon
2661
i3 Verticals
IIIV
$412M
$728K ﹤0.01%
36,180
+10,927
+43% +$269K
DSPG
2662
DELISTED
DSP Group Inc
DSPG
$727K ﹤0.01%
51,599
TSBK icon
2663
Timberland Bancorp
TSBK
$348M
$724K ﹤0.01%
26,314
+1,628
+7% +$42.8K
TACO
2664
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
$724K ﹤0.01%
70,754
PSNL icon
2665
Personalis
PSNL
$1.35B
$721K ﹤0.01%
+49,072
New +$928K
BLBD icon
2666
Blue Bird Corp
BLBD
$2.35B
$716K ﹤0.01%
37,582
CRK icon
2667
Comstock Resources
CRK
$3.89B
$713K ﹤0.01%
91,434
+53,397
+140% +$356K
HBCP icon
2668
Home Bancorp
HBCP
$561M
$709K ﹤0.01%
18,183
CSLT
2669
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$708K ﹤0.01%
501,667
+23,399
+5% +$46.6K
SMBC icon
2670
Southern Missouri Bancorp
SMBC
$852M
$706K ﹤0.01%
19,358
OPY icon
2671
Oppenheimer Holdings
OPY
$1.14B
$705K ﹤0.01%
23,426
SMBK icon
2672
SmartFinancial
SMBK
$896M
$703K ﹤0.01%
33,721
+4,576
+16% +$96.4K
NVAX icon
2673
Novavax
NVAX
$1.2B
$700K ﹤0.01%
139,286
+20,734
+17% +$113K
LXRX icon
2674
Lexicon Pharmaceuticals
LXRX
$1.03B
$697K ﹤0.01%
231,411
-37,503
-14% -$116K
ASXC
2675
DELISTED
Asensus Surgical, Inc.
ASXC
$693K ﹤0.01%
85,931
+1,832
+2% +$24.9K

Similar funds

Charles Schwab's Q3 2019 Portfolio in Review

As of Q3 2019, Charles Schwab held 3,259 positions worth $169B, up 3.1% from $164B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 4%. Charles Schwab opened 48 new positions and exited 81, leaving the 3,259-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q3 2019 buy was Blackstone: 1,331,026 shares worth $65M.
  • Charles Schwab added most to Fidelity National Information Services in Q3 2019, an estimated $167M increase.
  • Charles Schwab's biggest Q3 2019 reduction was Amcor, cutting an estimated $61.6M.
  • Charles Schwab fully exited Anadarko Petroleum in Q3 2019, selling an estimated $179M.
  • Charles Schwab's ten largest holdings make up 15% of its $169B portfolio in Q3 2019.
  • Charles Schwab opened 48 new positions and closed 81 in Q3 2019.
  • Charles Schwab's portfolio value rose 3.1% quarter-over-quarter to $169B.

Based on Charles Schwab's 13F filing for Q3 2019, filed 8 Nov 2019.